Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $120.0000 (0%) ($118.5000 - $120.0000) on Mon. Mar. 10, 2014. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.83% (three month average) | RSI | 49 | Latest Price | $120.0000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.6% a day on average for past five trading days. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IWM(7%) JNK(7%) PEJ(7%) SPY(7%) XLF(7%) | Factors Impacting CAPR price | CAPR will decline at least -5.915% in a week (0% probabilities). XHB(-4%) TLT(-3%) UUP(-2%) DIA(-2%) XLV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.915% (StdDev 11.83%) | Hourly BBV | 0 () | Intraday Trend | 1.3% | | | |
|
5 Day Moving Average | $118.9(0.93%) | 10 Day Moving Average | $117.45(2.17%) | 20 Day Moving Average | $118.01(1.69%) | To recent high | -22.6% | To recent low | 397.9% | Market Cap | $2.364b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |